Annotation Detail

Information
Associated Genes
KRAS
Associated Variants
KRAS MUTATION
KRAS MUTATION
Associated Disease
pseudomyxoma peritonei
Source Database
CIViC Evidence
Description
40 patients with pseudomyxoma peritonei underwent panel sequencing after cytoreductive surgery and hypertermic intraperitoneal chemotherapy (HIPEC). KRAS mutations were found in 72% of samples and KRAS mutations were independently associated with PFS (p=0.012) after multivariate analysis.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1596
Gene URL
https://civic.genome.wustl.edu/links/genes/30
Variant URL
https://civic.genome.wustl.edu/links/variants/336
Rating
3
Evidence Type
Prognostic
Disease
Pseudomyxoma Peritonei
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
27502722
Drugs